Patient, 60, is given alpha-radiation to target the tumor without harming healthy tissue in ‘historical’ procedure

In a European-wide clinical trial, Israeli scientists used laser and a drug made from deep-sea bacteria to treat men with prostate cancer, resulting in a 50 percent success rate.

A biodegradable balloon that isolates tumors from healthy tissues is able to minimize radiation exposure to healthy organs in prostate cancer sufferers. The technology, by Israeli startup BioProtect, is already marketed in Europe.